CD4 + Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy
Advanced Biology · 2023-04 · 7 (4)
DOI: 10.1002/adbi.202200169 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, online erschienen am 04.10.2022. Verfasst von Boyu Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, …. Hauptthemen laut MEDLINE: T-Lymphocytes, Cytotoxic, Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 98 Literaturangaben.
Abstract (Originalsprache)
CD4 + T cells have the ability to differentiate into relatively specialized effector subsets after exposure to innate immune signals. The remarkable plasticity of CD4 + T cells is required to achieve immune responses in different tissues and against various pathogens. Numerous studies have shown that CD4 + T cells can play direct and indispensable roles in protective immunity by killing infected or transformed cells. Although the lineage decision of commitment to the CD4 + or CD8 + cell lineage is once thought to be inflexible, the identification of antigen‐experienced CD4 + T cells with cytotoxic activity suggests the existence of unexpected plasticity for these cells. The recognition of CD4 + cytotoxic T lymphocytes (CTLs) and the mechanisms driving the differentiation of this particular cell subset create opportunities to explore the roles of these effector cells in protective immunity and immune‐related pathology. CD4 + CTLs are proven to play a protective role in antiviral immunity. Here, the latest investigations on the phenotypic and functional features of CD4 + CTLs and their roles in antitumor immunity and immunotherapy are briefly reviewed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Surgery Laboratory, Department of Thoracic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, 430030, P. R. China.
ORCID-Profile: Lequn Li
Zitieren
APA
Wang, B., Hu, S., Fu, X., & Li, L. (2023). CD4 + Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy. Advanced Biology, 7(4). https://doi.org/10.1002/adbi.202200169
Vancouver
Wang B, Hu S, Fu X, Li L. CD4 + Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy. Advanced Biology. 2023;7(4). doi:10.1002/adbi.202200169
BibTeX
@article{Wang2023,
author = {Wang, Boyu and Hu, Shaojie and Fu, Xiangning and Li, Lequn},
title = {CD4 + Cytotoxic T Lymphocytes in Cancer Immunity and Immunotherapy},
journal = {Advanced Biology},
year = {2023},
volume = {7},
number = {4},
doi = {10.1002/adbi.202200169}
}
EUVIMED